The role of n − 6 and n − 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease
Jessica Monteiro(University of Guelph), David W.L.(University of Guelph), Bianca M. Arendt(University Health Network), Johane P. Allard(University Health Network), M.A. Leslie(University of Guelph), Mohammed H. Moghadasian(University of Manitoba)
Cited by 81
Related Papers
The Impact of COVID-19 on Health Behavior, Stress, Financial and Food Security among Middle to High Income Canadian Families with Young Children
|Nutrients|2020|593
Comprehensive Profiling of Plasma Fatty Acid Concentrations in Young Healthy Canadian Adults
|PLoS ONE|2015|367
Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n‐3 and n‐6 polyunsaturated fatty acids
|Hepatology|2015|348
Are all n-3 polyunsaturated fatty acids created equal?
|Lipids in Health and Disease|2009|333